The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Mr Potter continues flogging a dead donkey as a stallion! pointless RNS, nothing we don't already know. More farm out discussions for another 2 years, line their pockets and fail again
agreed, seems all full of 'ifs' and 'maybs'/....classic potter/bpc
big plans but no indication of how they intend to fund
you are definitely braver than me! RNS is good but i suspect come the year end we can reflect on this RNS and i fairly confident targets will not be met.
Where are there planning to get the money from, no mention of concrete funding (have a look at UOG, proper concise roadmap and delivering every step of the way) ..oh yes, more dilution and sell the idea of owning 100% is better whilst diluting rather than earning 50% and not diluting. we'll probably get another RNS stating that the BOD will get a bonus if saf 2 hits oil. Just going by past performance here....lets see anyway. I will run for the hills if/when i recover some of my losses
Just finished reading the update, so they clearly missed their February timeline to Spud and are now talking of May (sound familiar??), they continue to quote big numbers £20million revenue by year end with 2500 bopd.
Watching closely but sounds like potter is on the rum again talking the big talk and missing deadlines set by himself in the process. I'm sure his parrot Uliel will pop up soon to sell the £20 million revenue story.
great deal struck there...CEO earning his cheddar here. now just need to get of aqse and on to a mpore recognised platform
yes, their feed from Aqius is rubbish, all over the place. I would ignore the price they are quoting. Have similar issue
i've typed in CBX but nothing coming up
can anyone buy on ii? can't seem to find it
The Company's shares are expected to commence trading under the ticker symbol CBX from 8am on Friday 26 February 2021, subject to the approval of its application for admission to the standard listing segment of the LSE. The prospectus, which has been approved by the Financial Conduct Authority, is available at www.cellulargoods.co .
this is going no where with potter still in place, he had his go. Needs to move on and bring in fresh blood. Company has achieved nothing in last 10 years besides dilution dilution dilution. From what i have read recently in the press the Bahamas seems to be a complete joke hole of a place to do business......lets see how it plays out
effectively wiping out the debt, setting up well here
World High Life PLC
("World High Life" or the "Company")
Issue of Equity
World High Life Plc (AQSE: LIFE) (OTCQB: WRHLF), announces that it has agreed to issue a total of 86,096,355 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") in settlement of £2,152,409 of debt.
Further to the Company's announcement on 3 February 2021, World High Life has received affirmative responses from the majority of the Convertible Debenture Holders for the conversion of the debentures into Ordinary Shares. Accordingly, Convertible Debentures totalling in principle £1,676,995 (amounting to £1,930,508 in total, with interest calculated to 15 March 2021) will be converted into a total of 77,220,315 Ordinary Shares at a price of 2.5p per share (the "Convertible Debenture Shares"). Each Convertible Debenture Share will be issued with 1 Share Purchase Warrant exercisable at 5p per share, vesting on 15 March 2021 and expiring on 14 March 2023 (the "Share Purchase Warrants").
World High Life has also agreed to issue 8,876,040 Ordinary Shares at a price of 2.5p per share in exchange for debt with an aggregate amount of £221,901 (the "Debt Shares").
Issuance of the Convertible Debenture Shares, Share Purchase Warrants and Debt Shares is subject to the passing of all resolutions at the General Meeting of the Company to be held on 11 March 2021.
Application will be made for the Convertible Debenture Shares and the and Debt Shares to be admitted to trading on the AQSE Growth Market and admission is expected to become effective, and dealings in the new Ordinary Shares are expected to commence, on or around 15 March 2021.
Andrew Male, Director of World High Life, commented
"With the issuance of this equity in exchange for debt, combined with the restructuring of the final consideration payable for Love Hemp, a total of £4,152,409 of debt has been removed from the balance sheet. This puts the Company in a positive position going forward with very little debt."
The Directors of the Company accept responsibility for the contents of this announcement.
About Love Hemp
Love Hemp is one of the UK's leading CBD and Hemp product suppliers and has more than 40 product lines, comprising oils, sprays and vapes and a variety of edible and water-based CBD products. Love Hemp has established relationships with over 1,500 stores in the UK, including leading brands such as Sainsbury's, Boots, Ocado and Holland & Barrett.
About World High Life
World High Life was established by the founders of Supreme Cannabis (TSX: FIRE), and 1933 Industries (CSE: TGIF), both companies at the forefront of the legalized cannabis industry. LIFE was established to take advantage of the huge opportunities available in the UK and European legal cannabis space, which is set to be the largest in the world within five years.
go to offers and ticker is cbx
primarybid.com
which platform you spread betting bpc on?